Malaysia’s largest listed integrated healthcare company, offering research and development, manufacturing, logistics, and distribution of pharmaceuticals and medical supplies. Pharmaniaga is capable of producing products in various forms; from oral solids, liquids and creams to small volume injectables. Its product portfolio encompasses a diverse segment of therapeutic areas such as cardiovascular, diabetes, anti-infectives, pain management, and respiratory, amongst others.
Established Since
1994
Annual Revenue
$50-100 million
Employees
3,500
Business Attribute
Agent/ Distributor
Manufacturer
Business Nature
Biotech/ Diagnostics/ Pharmaceutical/ Regenerative Medicine/ Preventive Medicine
Company Highlights
1
End-to-End Pharma Capability
Manufacturing generics, biopharma, OTC, vaccines & insulin; backed by six plants in Malaysia
2
Strong Logistics & Distribution Network
Extensive warehousing and distribution, 4 major centers in Malaysia and many branches in Indonesia; serving government and private sectors.
3
Regulatory & Quality Excellence
Plants comply with international GMP, PIC/S, ISO standards. Biopharma and vaccine fill-finish capabilities.
Market Presence
Headquartered in Shah Alam, Malaysia, Pharmaniaga serves both domestic and regional markets through its manufacturing, distribution, and hospital-equipment services in Malaysia.
Brands in Charge for Distribution
Generic pharmaceuticals. Biopharmaceuticals including vaccines, insulin (fill-finish). Over-the-counter (OTC) and nutraceutical products.
Strategic Focus Areas
Scale up biopharmaceutical manufacturing, strengthen vaccine & insulin fill-finish capabilities, expand medical devices & hospital equipment portfolio, and enhance supply chain resilience.